Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study.

by Colleen R Higgins, Betty Kobia, Sachiko Ozawa
Published 2023-01-01

Comparing the return on investment of technologies to detect substandard and falsified amoxicillin: A Kenya case study

by Colleen R. Higgins, Betty Kobia, Sachiko Ozawa
Published 2023-01-01

Nucleotides Regulate Secretion of the Inflammatory Chemokine CCL2 from Human Macrophages and Monocytes

by K. R. Higgins, W. Kovacevic, L. Stokes
Published 2014-01-01

Therapeutic High-Density Barium Enema in a Case of Presumed Diverticular Hemorrhage

by Nonthalee Pausawasdi, Mahmoud Al-Hawary, Peter D.R. Higgins
Published 2011-02-01

An Observational Cohort Study of <italic toggle="yes">Clostridium difficile</italic> Ribotype 027 and Recurrent Infection

by Krishna Rao, Peter D. R. Higgins, Vincent B. Young
Published 2018-06-01

Validation of a Laboratory-Developed Triplex Molecular Assay for Simultaneous Detection of Gastrointestinal Adenovirus and Rotavirus in Stool Specimens

by Rachel R. Higgins, Adriana Peci, Mark Cardona, Jonathan B. Gubbay
Published 2020-04-01

Comparisons in heart rate readings between the Bioconnected wireless exercise earpiece and a Polar T31-Coded Chest Strap during a GXT

by Trevor R. Higgins, Thomas Lloyd, Kenneth Manalansan, Sara McDonald, Ben Thomas
Published 2018-09-01

Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study

by Sachiko Ozawa, Daniel R. Evans, Colleen R. Higgins, Sarah K. Laing, Phyllis Awor
Published 2019-01-01

Vedolizumab more likely to be discontinued than ustekinumab in anti-TNF-experienced patients with fistulizing Crohn’s disease

by Kira L. Newman, Laura A. Johnson, Ryan W. Stidham, Peter D. R. Higgins
Published 2023-03-01

Serum Glycoproteome Profiles for Distinguishing Intestinal Fibrosis from Inflammation in Crohn's Disease.

by Ryan W Stidham, Jing Wu, Jiaqi Shi, David M Lubman, Peter D R Higgins
Published 2017-01-01

CT utilization abruptly increases at age 18 among patients with inflammatory bowel diseases in the hospital.

by Shail M Govani, Peter D R Higgins, Joel H Rubenstein, Ryan W Stidham, Akbar K Waljee
Published 2018-01-01

The economic impact of substandard and falsified antimalarial medications in Nigeria.

by Sarah M Beargie, Colleen R Higgins, Daniel R Evans, Sarah K Laing, Daniel Erim, Sachiko Ozawa
Published 2019-01-01

Blood–Brain Barrier Disruption Mediated by FFA1 Receptor—Evidence Using Miniscope

by Kristen L. Lindenau, Jeffrey L. Barr, Christopher R. Higgins, Kevin T. Sporici, Eugen Brailoiu, Gabriela C. Brailoiu
Published 2022-02-01

Importance of medicine quality in achieving universal health coverage.

by Sachiko Ozawa, Colleen R Higgins, Tatenda T Yemeke, Jude I Nwokike, Lawrence Evans, Mustapha Hajjou, Victor S Pribluda
Published 2020-01-01

Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model

by Kathryn D. Jackson, Colleen R. Higgins, Sarah K. Laing, Chiluba Mwila, Tamaki Kobayashi, Matthew M. Ippolito, Sean Sylvia, Sachiko Ozawa
Published 2020-07-01

95332 Intestinal inflammation and altered gut microbiota associated with inflammatory bowel disease render mice susceptible to Clostridioides difficile colonization and infection

by Lisa Abernathy-Closedeline R. Barron, James M. George, Kimberly C. Vendrov, Peter D.R. Higgins, Ingrid L. Bergin, Vincent B. Young
Published 2021-03-01

The Cape Town Declaration on Access to Cardiac Surgery in the Developing World

by P Zilla, M Yacoub, F Beyersdorf, R Higgins, R Bolman, L Zühlke, A Carpentier, K Sliwa, D Williams, B Mayosi
Published 2018-08-01

Correction: Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients.

by A Rogan, K McCarthy, G McGregor, T Hamborg, G Evans, S Hewins, N Aldridge, S Fletcher, N Krishnan, R Higgins, D Zehnder, S M Ting
Published 2017-01-01

Quality of life measures predict cardiovascular health and physical performance in chronic renal failure patients.

by A Rogan, K McCarthy, G McGregor, T Hamborg, G Evans, S Hewins, N Aldridge, S Fletcher, N Krishnan, R Higgins, D Zehnder, S M Ting
Published 2017-01-01

The Microbiome in Quiescent Crohn’s Disease With Persistent Symptoms Show Disruptions in Microbial Sulfur and Tryptophan Pathways

by Jonathan Golob, Krishna Rao, Jeffrey A. Berinstein, William D. Chey, Chung Owyang, Nobuhiko Kamada, Peter D.R. Higgins, Vincent Young, Shrinivas Bishu, Allen A. Lee
Published 2024-01-01